Integrating Peptide Science
The peptide field is evolving, with high-throughput platforms and biologically relevant systems driving the next generation of leads with powerful discovery platforms including AI/ML, high-throughput screening, and advanced display technologies. Integrating chemistry, biology, pharmacology, and data science continues this transformation of peptide drug discovery and development. As peptide therapeutics grow in complexity—from cyclic and stapled peptides to conjugates and multifunctional scaffolds—cross-disciplinary collaboration is critical for success. Also, while chemical synthesis remains a foundational tool, the integration of recombinant expression is expanding what's possible by offering scalable, sustainable, and cost-effective routes to complex peptides.
Explore how cutting-edge technologies are reshaping the peptide discovery landscape—from early screening to candidate development—and gain practical insights that translate directly to therapeutic innovation.
January 18
January 19-20
January 20-21
If you are working in the following areas join the PepTalk community:
- AI/ML
- Antibody-Peptide Conjugates (APCs)
- Bioinformatics
- Bioanalytical Development
- Biologics Discovery
- Cell Line Development
- High-Throughput Screening (HTS)
- Display Technologies (Phage/Ribosome/Yeast)
- Molecular Biology
- Peptide Characterization
- Peptide Chemistry
- Peptide Design
- Peptide Discovery
- Peptide Engineering
- Peptide Structure
- Peptidomics/Proteomics
- Protein Engineering
- Protein Expression and Purification
- Structural Biology
- Synthetic Biology
- Translational Science
- Target Identification and Validation
- Therapeutic Development
- Therapeutic Discovery